Table 2.

Association between PA domain and albuminuria among diabetic/prediabetic patients

	Model 1		Model 2		Model 3
Categorical variable
Albuminuria	OR (95%CI)	P value	OR (95%CI)	P value	OR (95%CI)	P value
Total PA
No	Reference		Reference		Reference
Yes	0.59 (0.50, 0.69)	< 0.001	0.66 (0.55, 0.79)	< 0.001	0.78 (0.64, 0.95)	0.014
Occupation-related PA
No	Reference		Reference		Reference
Yes	0.72 (0.58, 0.89)	0.003	0.82 (0.65, 1.03)	0.081	0.89 (0.70, 1.13)	0.327
Transportation-related PA
No	Reference		Reference		Reference
Yes	0.84 (0.66, 1.08)	0.168	0.89 (0.70, 1.13)	0.325	0.95 (0.74, 1.22)	0.690
Leisure-time PA
No	Reference		Reference		Reference
Yes	0.55 (0.44, 0.68)	< 0.001	0.60 (0.48, 0.74)	< 0.001	0.72 (0.56, 0.92)	0.009

	Model 1		Model 2		Model 3
Continuous variable
Ln ACR (mg/g)	β(95%CI)	P value	β(95%CI)	P value	β(95%CI)	P value
Total PA
No	Reference		Reference		Reference
Yes	− 0.15(− 0.19, − 0.11)	< 0.001	− 0.11(− 0.14, − 0.07)	< 0.001	− 0.06(− 0.10, − 0.03)	< 0.001
Occupation-related PA
No	Reference		Reference		Reference
Yes	− 0.09(− 0.13, − 0.05)	< 0.001	− 0.04(− 0.08, 0.00)	0.042	− 0.02(− 0.06, 0.01)	0.222
Transportation-related PA
No	Reference		Reference		Reference
Yes	− 0.05(− 0.11,0.00)	0.063	− 0.04(− 0.08, 0.01)	0.159	− 0.02(− 0.06, 0.03)	0.459
Leisure-time PA
No	Reference		Reference		Reference
Yes	− 0.15(− 0.19, − 0.12)	< 0.001	− 0.12(− 0.15, − 0.08)	< 0.001	− 0.07(− 0.11, − 0.03)	< 0.001

Model 1: None

Model 2: Age, gender, race/ethnicity

Model 3: Age, gender, race/ethnicity, marital status, PIR, education, BMI, smoking, alcohol status, CVD, hypertension, serum creatinine, uric acid, hyperlipidemia, anti-hypertensive drugs, and anti-diabetic drugs

ACR, Albumin/creatinine ratio; BMI, body mass index; PIR, poverty income ratio; CVD, cardiovascular disease; PA, physical activity; OPA, occupation-related PA; TPA, transportation-related PA; LTPA, leisure-time PA